MS Activists Celebrate Legislative Wins in Washington State
May 6, 2022
MS Activists in Washington made their voices heard on a variety of issues affecting the MS community as part of MS State Action Day. Both priority bills passed the legislature with bipartisan support.
- SB 5532: Prescription Drug Affordability Board will work to lower the cost of prescription medications in the state via an expert led review panel which will set policy to lower prices and make recommendations to the legislature for future actions.
- SB 5610 will direct all copays and manufacture assistance to be counted towards patients' deductible and out-of-pocket costs.
MS Activists made over 140 connections with lawmakers as part of MS State Action Day in February.
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.